Advertisement
Screener

Peak Bio, Inc. Forms 3, 4 and 5: Stock Options

Peak Bio, Inc. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2024-11-14: Reporting owner Patel Sandip I; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2024-11-14: Reporting owner Neal James R; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2024-11-14: Reporting owner Huh Hoyoung; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2022-11-01: Reporting owner Mitra Satyajit Kumar; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2024-11-14Patel Sandip I
Director
4Stock Option (Right to Buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
0 owned after
$0.80
exercise price
2024-11-18
2024-11-14Neal James R
Director
4Stock Option (Right to Buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
0 owned after
$0.80
exercise price
2024-11-18
2024-11-14Huh Hoyoung
Director, 10% Owner
4Stock Option (Right to Buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
0 owned after
$0.80
exercise price
2024-11-18
2022-11-01Mitra Satyajit Kumar
Officer (See Remarks)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+18,647
18,647 owned after
$6.10
exercise price
2022-11-03
2022-11-01Mitra Satyajit Kumar
Officer (See Remarks)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+31,700
31,700 owned after
$8.05
exercise price
2022-11-03
2022-11-01LaMond Stephen J
Director, Officer (See Remarks)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+65,265
65,265 owned after
$8.05
exercise price
2022-11-03